Etravirine

Contraindicated

Etravirine Maraviroc Selzentry Decreased maraviroc plasma concentrations and exposure (AUC) Details

Major

Etravirine Acetaminophen And Codeine Capital® & Codeine Explained Reduced codeine and morphine exposure, reduced opioid efficacy and precipitation of opioid withdrawal Details Etravirine Buprenorphine Belbuca Explained Reduced buprenorphine exposure and reduced efficacy of buprenorphine Details Etravirine Atogepant Qulipta Reduced atogepant exposure Details Etravirine Avapritinib Ayvakit Reduced avapritinib exposure and reduced efficacy of avapritinib Details Etravirine Azathioprine Azasan An increased risk of hepatotoxicity Details Etravirine Cariprazine Vraylar Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Etravirine Aficamten Reduced aficamten exposure and reduced efficacy of aficamten Details Etravirine Amlodipine Amvaz® Reduced amLODIPine exposure Details Etravirine Avanafil Stendra Altered avanafil plasma concentrations Details Etravirine Axitinib Inlyta Reduced axitinib exposure Details Etravirine Bedaquiline Sirturo Reduced bedaquiline exposure and reduced efficacy of bedaquiline Details Etravirine Brigatinib Alunbrig Decreased brigatinib exposure and efficacy Details Etravirine Cabotegravir Apretude Loss of virologic response and possible development of viral resistance Details Etravirine Cabozantinib Cabometyx Reduced cabozantinib exposure and reduced efficacy of cabozantinib Details Etravirine Cabozantinib (Thyroid Cancer) Cabometyx Reduced cabozantinib exposure and reduced efficacy of cabozantinib Details Etravirine Capecitabine Xeloda Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Etravirine Capmatinib Tabrecta Decreased capmatinib exposure and reduction of antitumor activity Details Etravirine Cyclosporine Injection Atopica Reduced cycloSPORINE exposure Details Etravirine Cyclosporine Ophthalmic Cequa Reduced cycloSPORINE exposure Details Etravirine Deflazacort Emflaza Decreased exposure to active metabolite of deflazacort Details Etravirine Dexamethasone Injection Decadron Decreased etravirine plasma concentrations Details Etravirine Dexamethasone Ophthalmic Dexacidin® (as a combination product containing Dexamethasone, Neomycin, Polymyxin B) Decreased etravirine plasma concentrations Details Etravirine Diazepam Nasal Spray Valtoco Increased diazepam plasma concentrations Details Etravirine Diazepam Rectal Diastat Increased diazepam plasma concentrations Details Etravirine Disopyramide Norpace Decreased disopyramide plasma concentrations Details Etravirine Dolutegravir Juluca® (as a combination product containing dolutegravir, rilpivirine) Reduced dolutegravir exposure and reduced efficacy of dolutegravir Details Etravirine Doravirine Pifeltro Decreased doravirine plasma concentration and reduced efficacy; increased risk of doravirine resistance Details Etravirine Doxorubicin Adriamycin Reduced DOXOrubicin exposure Details Etravirine Elacestrant Orserdu Reduced elacestrant exposure and reduced efficacy of elacestrant Details Etravirine Encorafenib Braftovi Reduced encorafenib exposure and reduced efficacy of encorafenib Details Etravirine Entrectinib Rozlytrek Reduced entrectinib exposure and reduced efficacy of entrectinib Details Etravirine Erdafitinib Balversa Reduced erdafitinib exposure Details Etravirine Estradiol Delestrogen Reduced hormonal contraceptive exposure, reduced efficacy of hormonal contraceptive and increased risk of breakthrough bleeding an... Details Etravirine Estradiol Topical Divigel Reduced hormonal contraceptive exposure, reduced efficacy of hormonal contraceptive and increased risk of breakthrough bleeding an... Details Etravirine Estradiol Transdermal Patch Alora® Reduced hormonal contraceptive exposure, reduced efficacy of hormonal contraceptive and increased risk of breakthrough bleeding an... Details Etravirine Fentanyl Transdermal Patch Duragesic® Reduced exposure of fentaNYL, reduced efficacy of fentaNYL and/or onset of opioid withdrawal symptoms Details Etravirine Finerenone Kerendia Reduced finerenone exposure and reduced efficacy of finerenone Details Etravirine Flecainide Tambocor® Decreased flecainide plasma concentrations Details Etravirine Fluorouracil Adrucil Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details